Interactions on record — worth a quick check against your medications. Based on 2 of 15 ingredients. Check your meds →
Dietary supplement

High Grade Hemp Full Spectrum Cannabinoids Veggie Caps Ingredients & Drug Interactions

by etst Earth Science Tech

Capsule Category: Non-nutrient/non-botanical
Most serious interaction: Moderate
The interaction bottom line Most serious interaction: Moderate

High Grade Hemp Full Spectrum Cannabinoids Veggie Caps is a dietary supplement by etst Earth Science Tech with 15 active ingredients. Its ingredients are commonly taken for heartburn and acid reflux, digestive upset, stress and mood support.Based on those ingredients, 939 medications have a known interaction with it, the most serious rated moderate. The ingredients most likely to interact are Eucalyptol, Limonene. Use the checker below to test your specific medication, or read the full HelloPharmacist Interaction Report.

HelloPharmacist Scorecard of High Grade Hemp Full Spectrum Cannabinoids Veggie Caps by etst Earth Science Tech

Our pharmacy team’s full take, with four database checks built into the cards below — a summary of what is known, not a grade of the product itself.

From our pharmacy team — supplement deep dive

What’s inside

Low disclosure
Ingredient Transparency · database check
Low

Most active ingredients don't disclose an individual amount — you can't tell how much of each you're getting.

Why this rating?
  • The label discloses an exact amount for 6 of its 15 active ingredients.
  • “Cannabinoid Complex” is a proprietary blend — the label gives one combined amount (75 mg) without saying how much of each component you get.
  • “Terpenoid” is listed as a grouped ingredient — the label gives one combined amount (0.16 mg) without saying how much of each component you get.

This product contains 15 active ingredients, most of them cannabinoids and terpenes derived from hemp. The main players you'll see listed are limonene, myrcene, eucalyptol, and various cannabinoids (cannabidiol, tetrahydrocannabinol, cannabinol, and others) — compounds naturally present in cannabis plants.

The inactive ingredients are coconut MCT oil, cellulose, sunflower lecithin, silica, and vitamin E, which serve as the capsule base and carrier.

Does it work?

Couldn't assess
Evidence for Intended Use · database check
By FDA rules, dietary supplements can’t claim to treat, cure, or prevent disease — so labels speak in careful marketing language. We discern each product’s intended use from its name, label claims, and label statements, then grade the clinical evidence for that use. How these ratings are computed
Not assessable

The label doesn't state a purpose we can grade — see each ingredient's own graded uses on its monograph instead.

Why this rating?
  • We looked at the product name, claims, and label statements and couldn't find a stated purpose to grade.

The evidence we hold for the active ingredients in this product does not establish their effectiveness for any condition. Limonene's data shows insufficient reliable evidence for cancer and irritable bowel syndrome.

Eucalyptol similarly shows insufficient evidence for acne, bronchitis, asthma, burns, and cancer. For the cannabinoids and other terpenes, we have no effectiveness ratings on file.

The evidence, ingredient by ingredient Limonene Eucalyptus

How safe is it?

Well-documented data
Safety Information · database check
Well characterized

Adverse-effect, pregnancy, and general safety data are on file for most of these ingredients.

Why this rating?
  • We hold adverse-effect (side-effect) data for 2 of the 2 matched ingredients.
  • Pregnancy & breastfeeding safety ratings cover 2 of 2.
  • General safety write-ups exist for 2 of 2.
  • Remember: this measures how much safety information exists. Thin data is not the same as being safe.

Limonene is generally well tolerated in food amounts, but high-dose supplement safety data in humans is limited. Orally, it can cause nausea, vomiting, and diarrhea.

When inhaled (as might happen with aromatic exposure), limonene from household products has been linked to wheezing and asthma, especially in children. Eucalyptol in diluted or inhaled form is generally considered safe in small amounts, but the undiluted oil is toxic if swallowed and can cause serious effects including seizures, coma, and death even at doses as low as 1 mL.

Topically it may cause burning, itching, or redness. For pregnancy, the data we hold shows limonene safety is insufficient — there isn't enough information to know either way — so you should talk with your doctor or pharmacist about use during pregnancy.

Limonene is rated likely safe while breastfeeding. Eucalyptol is rated likely safe for both pregnancy and breastfeeding.

For the cannabinoids and other terpenes in this product, we have no pregnancy or breastfeeding safety data on file.

Side effects, ingredient by ingredient Limonene Eucalyptus

Meds to double-check

Moderate interaction found
Known Interaction Concern · database check
Moderate identified

The most serious documented interaction for these ingredients is Moderate. Check your medications for a personalized result.

Why this rating?
  • 2 of the 2 matched ingredients can interact with medications — Eucalyptus, Limonene.
  • The most serious interaction on file is rated Moderate.
  • Some involve high-stakes drug classes: diabetes medications.
  • For scale: 940 individual medications appear in the full list. A big number alone doesn't make a product dangerous — what matters is whether YOUR medication is on it, so run yours through the interaction checker on this page.

Before taking this product, double-check these medication types with your doctor or pharmacist: drugs that depend on CYP2C19, CYP2C9, CYP1A2, and CYP3A4 metabolism (which includes many heart, blood pressure, and psychiatric medications); diabetes drugs; amphetamines; and pentobarbital. If you're on any prescription medication, the medication checker below will help you confirm whether it's safe to combine.

Check your own medication Run your meds through the checker above

The bottom line

Scorecard at a glanceFormula with limited ingredient disclosure with no assessable stated purpose. Moderate medication interactions have been identified, and safety information is well characterized.

This product is a full-spectrum hemp formulation with cannabinoids and terpenes. Because limonene and eucalyptol both interact with medications that pass through your liver, anyone on prescription drugs — especially those for diabetes, heart rhythm, anticoagulation, or depression — should check their specific medications with the tool on this page before starting.

Talk with your doctor or pharmacist about whether this product fits your health situation and medications.

Educational only — not medical advice; always confirm with your pharmacist. Our editorial policy · How we use AI

Assessment coverage: 2 of 15 active ingredients matched to our full ingredient reviews (monographs). Based on the product label dated Jun 16, 2022.

This Scorecard evaluates available label information, ingredient evidence, and known medication-safety considerations. It does not independently verify product identity, purity, potency, contamination, or manufacturing quality. How these ratings are computed

At a glance

General information

Key facts about High Grade Hemp Full Spectrum Cannabinoids Veggie Caps, straight from the product label.

Brand etst Earth Science Tech
Barcode (UPC) 857516005568
Net contents 30 Veggie Cap(s)
Market status On market
Date entered into DSLD Jun 16, 2022
DSLD ID 266645
Product type Non-nutrient/non-botanical
Supplement form Capsule
Dietary claims / uses All Other, Structure/Function
Intended target group(s) Adult (18 - 50 Years), Women (not pregnant or lactating)
From the label
Everything in this section is reproduced from the manufacturer’s own product label — it’s the label speaking, not HelloPharmacist. We show it so you can see exactly what the maker states; we don’t verify or endorse those statements.

Supplement Facts

The label details for High Grade Hemp Full Spectrum Cannabinoids Veggie Caps by etst Earth Science Tech, sourced from the NIH Dietary Supplement Label Database.

Supplement Facts

Daily Value (DV) Target Group(s):
Adults and children 4 or more years of age
Minimum serving Sizes:
1 Veggie Cap(s)
Maximum serving Sizes:
1 Veggie Cap(s)
Servings per container
30
UPC/BARCODE
857516005568
IngredientAmount% DV
Limonene0 NP--
Myrcene0 NP--
Cannabichromene3.4 mg--
Cannabinol0.2 mg--
Cannabidiol29 mg--
Cannabigerol0.6 mg--
Cannabidiolic Acid42 mg--
Linalool0 NP--
Eucalyptol0 NP--
Tetrahydrocannabinol0 NP--
Cannabivarin0.1 mg--
Cannabinoid Complex75 mg--
Terpenoid0.16 mg--
Bisabolol0 NP--
Pinene0 NP--
Caryophyllene0 NP--
Humulene0 NP--

Other ingredients: Coconut MCT Oil, Cellulose, Sunflower Lecithin, Silica, Vitamin E

Tap any ingredient to jump to its full detail below.

Label statements
These statements are the manufacturer’s wording, reproduced from the product label — the label is saying it, not HelloPharmacist. We don’t verify or endorse them.
Formula

High Grade-A full spectrum cannabinoid oil derived from industrial hemp.

This product naturally contains phyto-cannabinoids, terpenoids, amino acids, flavonoids and other nutrients.

Full Spectrum Cannabinoid (Phytocannabinoid) hemp. Industrial hemp oil naturally containing CBD, CBDa, CBDV, CBC, CBN, CBG, & terpenes

2,259 mg +/- Total Cannabinoids 5 mg +/- Total Terpenoids 75 mg +/- Cannabinoids per serving 0.16 mg +/- Terpenoids per serving

FDA Disclaimer Statement

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Seals/Symbols

GMP Good Manufacturing Practice Product Made in USA Found On Verifyhemp.com Certified Hemp Reports

Suggested/Recommended/Usage/Directions

Suggested use Take 1 veggie cap 1-2 times daily or as needed.

Precautions

Do not take if you are pregnant or lactating.

Always consult a medical doctor before modifying your diet or using any new product.

See for yourself

High Grade Hemp Full Spectrum Cannabinoids Veggie Caps by etst Earth Science Tech label

The label scan from the NIH Dietary Supplement Label Database. Tap to enlarge.

What’s inside

The Ingredients in High Grade Hemp Full Spectrum Cannabinoids Veggie Caps by etst Earth Science Tech

These are the 15 active ingredients this product is made of. Select any to open its full monograph.

Serving size1 Veggie Cap(s) Dosage formCapsule Servings per container30 Amounts shown are per serving.

Most supplement products combine several ingredients, and a medication can interact with the product through any one of them. Each ingredient below shows whether it has known drug interactions.

Tetrahydrocannabinol

0 NP per serving

Cannabinoid Complex

75 mg per serving
  • › Cannabichromene
  • › Cannabinol
  • › Cannabidiol
  • › Cannabigerol
  • › Cannabidiolic Acid
  • › Cannabivarin

Terpenoid

0.16 mg per serving
  • Limonene
  • › Myrcene
  • › Linalool
  • Eucalyptol
  • › Bisabolol
  • › Pinene
  • › Caryophyllene
  • › Humulene

Other (inactive) ingredients: Coconut MCT Oil, Cellulose, Sunflower Lecithin, Silica, Vitamin E. These complete the product’s ingredient list but are not active constituents.

Interaction report

High Grade Hemp Full Spectrum Cannabinoids Veggie Caps by etst Earth Science Tech Drug Interactions

Want to check YOUR meds against High Grade Hemp Full Spectrum Cannabinoids Veggie Caps?

Ask about interactions with your drugs in plain English — “Can I take it with lisinopril?” — and we find you the answer in seconds, ingredient by ingredient.

Go to the checker
939Drugs
939 Moderate

Ingredients driving the most interactions

Limonene 229

Each ingredient & the kinds of drugs it affects

For each ingredient in High Grade Hemp Full Spectrum Cannabinoids Veggie Caps with known interactions, here are the types of medications they can affect. Open any type for the detail — or search your exact drug in the checker above.

Eucalyptol7 drug types · 878 drugs

Amphetamines

Theoretically, inhaling eucalyptol may reduce the effectiveness of amphetamines.
Animal research suggests that inhaling eucalyptol may reduce the levels of amphetamines in the blood.

Likelihood Possible Evidence D
Antidiabetes Drugs

Theoretically, eucalyptus leaf might increase the risk of hypoglycemia.
Animal research suggests that eucalyptus leaf might have hypoglycemic activity, and might have additive effects when used with antidiabetes drugs.

Likelihood Possible Evidence D
Cytochrome P450 1A2 (Cyp1A2) Substrates

Theoretically, eucalyptus might increase the levels of CYP1A2 substrates.
In vitro research suggests that eucalyptus oil might inhibit CYP1A2, although this has not been reported in humans.

Likelihood Possible Evidence D
Cytochrome P450 2C19 (Cyp2C19) Substrates

Theoretically, eucalyptus might increase the levels of CYP2C19 substrates.
In vitro research suggests that eucalyptus oil might inhibit CYP2C19, although this has not been reported in humans.

Likelihood Possible Evidence D
Cytochrome P450 2C9 (Cyp2C9) Substrates

Theoretically, eucalyptus might increase the levels of CYP2C9 substrates.
In vitro research suggests that eucalyptus oil might inhibit CYP2C9, although this has not been reported in humans.

Likelihood Possible Evidence D
Cytochrome P450 3A4 (Cyp3A4) Substrates

Theoretically, eucalyptus might increase the levels of CYP3A4 substrates.
In vitro research suggests that eucalyptus oil might inhibit CYP3A4, although this has not been reported in humans.

Likelihood Possible Evidence D
Pentobarbital (Nembutal)

Theoretically, inhaling eucalyptol might reduce the effectiveness of pentobarbital.
Animal research suggests that inhaling eucalyptol reduces the level of pentobarbital that reaches the brain.

Likelihood Possible Evidence D

Limonene5 drug types · 229 drugs

Cytochrome P450 2C19 (Cyp2C19) Inducers

There's preliminary evidence that limonene might be a substrate for cytochrome P450 2C19 (CYP2C19). CYP2C19 inducers might decrease the effects of limonene. So far, this interaction has not been reported in humans. Inducers of CYP2C19 include carbamazepine (Tegretol), prednisone (Deltasone), and rifampin (Rifadin, Rimactane).

Likelihood Possible Evidence D
Cytochrome P450 2C19 (Cyp2C19) Inhibitors

There's preliminary evidence that limonene might be a substrate for cytochrome P450 2C19 (CYP2C19). So far, this interaction has not been reported in humans. However, watch for an increase in the limonene levels when it is taken with drugs that inhibit CYP2C19. Some drugs that inhibit CYP2C19 include cimetidine (Tagamet), fluvoxamine (Luvox), omeprazole (Prilosec); ticlopidine (Ticlid), topiramate (Topamax), and others.

Likelihood Possible Evidence D
Cytochrome P450 2C9 (Cyp2C9) Inducers

There's preliminary evidence that limonene might be a substrate for cytochrome P450 2C9 (CYP2C9). Inducers of CYP2C9 might decrease limonene levels. Inducers of CYP2C9 include rifampin (Rifadin, Rimactane) and secobarbital (Seconal).

Likelihood Possible Evidence D
Cytochrome P450 2C9 (Cyp2C9) Inhibitors

There's preliminary evidence that limonene might be a substrate for cytochrome P450 2C9 (CYP2C9). So far, this interaction has not been reported in humans. However, watch for side effects in patients taking limonene and CYP2C9 inhibitors. Some CYP2C9 inhibitors include amiodarone (Cordarone), fluconazole (Diflucan), lovastatin (Mevacor), paroxetine (Paxil), zafirlukast (Accolate), and many others.

Likelihood Possible Evidence D
Cytochrome P450 2C9 (Cyp2C9) Substrates

There's preliminary evidence that limonene might be a substrate for cytochrome P450 2C9 (CYP2C9), as well causing its induction. So far, this interaction has not been reported in humans. However, watch for a decrease in the levels of drugs metabolized by CYP2C9 in patients taking limonene. Some drugs metabolized by CYP2C9 include nonsteroidal anti-inflammatory drugs (NSAIDs) such as diclofenac (Cataflam, Voltaren), ibuprofen (Motrin), meloxicam (Mobic), and piroxicam (Feldene); celecoxib (Celebrex); amitriptyline (Elavil); warfarin (Coumadin); glipizide (Glucotrol); losartan (Cozaar); and others.

Likelihood Possible Evidence D
The maker

Brand information

Manufacturer and brand details for High Grade Hemp Full Spectrum Cannabinoids Veggie Caps, from the product label.

etst Earth Science Tech

Name
Earth Science Tech
City
Doral
State
Florida
ZipCode
33122
Phone Number
1-305-615-2118
Web Address
www.earthsciencetech.com
Pharmacist Counseling Corner

High Grade Hemp Full Spectrum Cannabinoids Veggie Caps by etst Earth Science Tech: Common Questions

Does High Grade Hemp Full Spectrum Cannabinoids Veggie Caps by etst Earth Science Tech interact with any medications?
Yes. Based on its ingredients, High Grade Hemp Full Spectrum Cannabinoids Veggie Caps has a known interaction with 939 medications. Use the checker to see how it interacts with a specific drug.
How can one product interact with so many drugs?
High Grade Hemp Full Spectrum Cannabinoids Veggie Caps contains 15 active ingredients, and an interaction can come from any of them. We check every ingredient, combine the results into one list per medication, and show which ingredient and mechanism is responsible.
Where does this information come from?
The product label data comes from the NIH Dietary Supplement Label Database (DSLD); the interaction data is built on the Natural Medicines database and reviewed by HelloPharmacist pharmacists.
Can I take this if I'm breastfeeding?
Limonene is rated likely safe while breastfeeding, and eucalyptol is also rated likely safe. However, we have no breastfeeding safety data for the cannabinoids and other terpenes in this product. Talk with your doctor or pharmacist about your individual situation before starting.
What does limonene do in this product?
Limonene is a terpene — a naturally aromatic compound found in hemp and citrus plants. The evidence we have doesn't establish that it's effective for any specific condition. Its main concern here is that it may affect how your body processes certain medications.
Will this help with my condition?
We don't have established effectiveness data for the ingredients in this product for any health condition. The evidence for limonene and eucalyptol, as well as the cannabinoids, is either insufficient or not on file. Talk with your doctor about whether this product might help your situation.
What side effects can limonene cause?
Taken by mouth, limonene can cause nausea, vomiting, and diarrhea. When inhaled in air (for example, from household cleaners), it's been linked to wheezing and asthma, especially in children. In general, it's well tolerated in food amounts, but high-dose supplement safety data in humans is limited.
Is eucalyptol safe to swallow in this product?
The undiluted eucalyptus oil can be toxic if swallowed — even 1 mL can cause serious effects like seizures, coma, and death. This product contains eucalyptol as part of a full-spectrum blend at what we assume is a diluted level, but you should talk with your doctor or pharmacist about whether this form is safe for you to take by mouth.

Written and reviewed by the HelloPharmacist editorial staff. Our editorial policy

Not sure if High Grade Hemp Full Spectrum Cannabinoids Veggie Caps is safe with your meds?

Our pharmacists answer your medication & supplement questions — free.

Ask a pharmacist

Label information is sourced from the NIH Dietary Supplement Label Database and reflects the product version on file; always read your actual product label. This page is for education only and is not a substitute for professional medical advice. Confirm with your pharmacist or doctor before combining supplements and medications.

High Grade Hemp Full Spectrum Cannabinoids Veggie Caps label
Sources

Sources & How We Checked

High Grade Hemp Full Spectrum Cannabinoids Veggie Caps's label data comes from the NIH Dietary Supplement Label Database; the ingredient interaction data is from the Natural Medicines database, reviewed by our pharmacists.

Content is written and reviewed by licensed HelloPharmacist pharmacists. See our data sources and editorial standards for how this information is built and checked.

The 33 references behind this product’s interaction data

Every citation that drives the interaction findings for this product’s ingredients, from the evidence-graded Natural Medicines (TRC Healthcare) database. Open an ingredient to browse its citations — links open the study on PubMed or the publisher’s site.

Limonene 10 references
  1. Electronic Code of Federal Regulations. Title 21. Part 182 -- Substances Generally Recognized As Safe. Available at: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?CFRPart=182
  2. Vigushin DM, Poon GK, Boddy A, et al. Phase I and pharmacokinetic study of D-limonene in patients with advanced cancer. Cancer Research Campaign Phase I/II Clinical Trials Committee. Cancer Chemother Pharmacol 1998;42:111-7. PubMed
  3. Crowell PL. Prevention and therapy of cancer by dietary monoterpenes. J Nutr 1999;129:775S-778S. PubMed
  4. Matura M, Goossens A, Bordalo O, et al. Oxidized citrus oil (R-limonene): a frequent skin sensitizer in Europe. J Am Acad Dermatol 2002;47:709-14. PubMed
  5. Topham EJ, Wakelin SH. D-Limonene contact dermatitis from hand cleansers. Contact Dermatitis 2003;49:108-9.
  6. Miyazawa M, Shindo M, Shimada T. Metabolism of (+)- and (-)-limonenes to respective carveols and perillyl alcohols by CYP2C9 and CYP2C19 in human liver microsomes. Drug Metab Dispos 2002;30:602-7. PubMed
  7. Dales RE, Cakmak S. Is residential ambient air limonene associated with asthma? Findings from the Canadian Health Measures Survey. Environ Pollut 2019;244:966-70. PubMed
  8. Dittmar D, Schuttelaar MLA. Contact sensitization to hydroperoxides of limonene and linalool: results of consecutive patch testing and clinical relevance. Contact Dermatitis 2019;80(2):101-9. PubMed
  9. Gatica-Ortega ME, Pastor-Nieto MA, Schoendorff-Ortega C, Mollejo-Villanueva M, Giménez-Arnau A. Lymphomatoid contact dermatitis caused by limonene hydroperoxides confirmed by an exposure provocation test with the involved personal hygiene products. Contac PubMed
  10. Nath NS, Liu B, Green C, Atwater AR. Contact allergy to hydroperoxides of linalool and D-limonene in a US population. Dermatitis 2017;28(5):313-6. PubMed

See these in context on the Limonene monograph →

Eucalyptus 23 references
  1. Electronic Code of Federal Regulations. Title 21. Part 182 -- Substances Generally Recognized As Safe. Available at: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?CFRPart=182
  2. Unger M, Frank A. Simultaneous determination of the inhibitory potency of herbal extracts on the activity of six major cytochrome P450 enzymes using liquid chromatography/mass spectrometry and automated online extraction. Rapid Commun Mass Spectrom 2004;1 PubMed
  3. De Vincenzi M, Silano M, De Vincenzi A, et al. Constituents of aromatic plants: eucalyptol. Fitoterapia 2002;73:269-75. PubMed
  4. Gray AM, Flatt PR. Antihyperglycemic actions of Eucalyptus globulus (Eucalyptus) are associated with pancreatic and extra-pancreatic effects in mice. J Nutr 1998;128:2319-23. PubMed
  5. Whitman BW, Ghazizadeh H. Eucalyptus oil: therapeutic and toxic aspects of pharmacology in humans and animals. J Paediatr Child Health 1994;30:190-1. PubMed
  6. Barker SC and Altman PM. An ex vivo, assessor blind, randomised, parallel group, comparative efficacy trial of the ovicidal activity of three pediculicides after a single application--melaleuca oil and lavender oil, eucalyptus oil and lemon tea tree oil,
  7. Vilaplana, J. and Romaguera, C. Allergic contact dermatitis due to eucalyptol in an anti-inflammatory cream. Contact Dermatitis 2000;43(2):118.
  8. Juergens, U. R. [Reducing the need for cortisone. Does eucalyptus oil work in asthma? (interview by Brigitte Moreano]. MMW.Fortschr Med 3-29-2001;143(13):14.
  9. Tascini, C., Ferranti, S., Gemignani, G., Messina, F., and Menichetti, F. Clinical microbiological case: fever and headache in a heavy consumer of eucalyptus extract. Clin Microbiol.Infect. 2002;8(7):437, 445-437, 446. PubMed
  10. Galdi, E., Perfetti, L., Calcagno, G., Marcotulli, M. C., and Moscato, G. Exacerbation of asthma related to Eucalyptus pollens and to herb infusion containing Eucalyptus. Monaldi Arch.Chest Dis. 2003;59(3):220-221.
  11. Spoerke, D. G., Vandenberg, S. A., Smolinske, S. C., Kulig, K., and Rumack, B. H. Eucalyptus oil: 14 cases of exposure. Vet Hum.Toxicol 1989;31(2):166-168.
  12. Jori, A., Bianchetti, A., Prestini, P. E., and Gerattini, S. Effect of eucalyptol (1,8-cineole) on the metabolism of other drugs in rats and in man. Eur.J Pharmacol 1970;9(3):362-366. PubMed
  13. Tibballs, J. Clinical effects and management of eucalyptus oil ingestion in infants and young children. Med J Aust 8-21-1995;163(4):177-180. PubMed
  14. Webb, N. J. and Pitt, W. R. Eucalyptus oil poisoning in childhood: 41 cases in south-east Queensland. J Paediatr.Child Health 1993;29(5):368-371. PubMed
  15. Gyldenløve M, Menné T, Thyssen JP. Eucalyptus contact allergy. Contact Dermatitis. 2014;71(5):303-304. PubMed
  16. Higgins C, Palmer A, Nixon R. Eucalyptus oil: contact allergy and safety. Contact Dermatitis. 2015;72(5):344-346. PubMed
  17. de Groot AC, Schmidt E. Eucalyptus oil and tea tree oil. Contact Dermatitis. 2015;73(6):381-386. PubMed
  18. Greive KA, Barnes TM. The efficacy of Australian essential oils for the treatment of head lice infestation in children: A randomised controlled trial. Australas J Dermatol. 2018;59(2):e99-e105. PubMed
  19. Paulsen E, Thormann H, Vestergaard L. Eucalyptus species as a cause of airborne allergic contact dermatitis. Contact Dermatitis. 2018;78(4):301-303.
  20. Mathew T, John SK, Kamath V, et al. Essential oil related seizures (EORS): A multi-center prospective study on essential oils and seizures in adults. Epilepsy Res. 2021;173:106626. PubMed
  21. Dudipala SC, Mandapuram P, Ch LK. Eucalyptus Oil-Induced Seizures in Children: Case Reports and Review of the Literature. J Neurosci Rural Pract 2021;12(1):112-115. PubMed
  22. Panda PK, Sharawat IK, Panda P, Dawman L, Kasinathan A. Clinico-laboratory characteristics and outcome of patients with eucalyptus oil-induced/provoked seizures: A case series and systematic review of the published patients. Trop Doct 2021;51(4):518-522. PubMed
  23. Sai Chandar D, Prashanthi M, Laxman Kumar C, Amith Kumar C. Eucalyptus Oil-Induced Seizures in Children: A Single-Center Prospective Study. Cureus 2021;13(3):e14109. PubMed

See these in context on the Eucalyptus monograph →

Parts of this content are provided by the Therapeutic Research Center, LLC.

DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.

© 2021 Therapeutic Research Center, LLC

Keep exploring